Home » Topics » BioWorld

BioWorld
RSS

BELGIUM APPROVES BTGC GROWTH HORMONE

Feb. 3, 1992

GENELABS DEAL FOR ANTI-CANCER DRUG

Feb. 3, 1992

APPOINTMENTS AND ADVANCEMENTS

Feb. 3, 1992

SOMATIX LICENSES MYOBLAST GENE THERAPY

Feb. 3, 1992

FEDERAL BIOTECH PRIORITIES FOR 21st CENTURY

Feb. 3, 1992

JUDGE REFUSES TO SET ASIDE XOMA RULING

Feb. 3, 1992

$687 MILLION IN OFFERINGS FOR MONTH

Feb. 3, 1992

FDA PANEL TURNS DOWN U.S. BIO'S ETHYOL

Feb. 3, 1992

GENSIA TO EVALUATE EYE TREATMENT

Jan. 31, 1992

POSITIVE RESULTS FROM AIDS VACCINE TRIAL

Jan. 31, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...